Lantheus Holdings, Inc. (LNTH) Downgraded by Zacks Investment Research
Lantheus Holdings, Inc. (NASDAQ:LNTH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. “
LNTH has been the subject of several other research reports. Jefferies Group LLC reaffirmed a “buy” rating and set a $18.00 target price on shares of Lantheus Holdings in a research note on Friday, June 30th. BidaskClub cut Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 17th. Credit Suisse Group raised their target price on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Finally, Cantor Fitzgerald started coverage on Lantheus Holdings in a research note on Monday, July 17th. They set an “overweight” rating and a $22.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $18.60.
Shares of Lantheus Holdings (LNTH) opened at 17.25 on Wednesday. Lantheus Holdings has a 12 month low of $7.61 and a 12 month high of $17.65. The firm has a market capitalization of $644.29 million, a price-to-earnings ratio of 23.57 and a beta of 0.94. The company has a 50-day moving average price of $17.23 and a 200-day moving average price of $17.23.
Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings data on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.18. Lantheus Holdings had a negative return on equity of 37.47% and a net margin of 8.44%. The company had revenue of $88.83 million during the quarter, compared to the consensus estimate of $80.56 million. During the same period last year, the company earned $0.24 earnings per share. The firm’s revenue was up 13.9% compared to the same quarter last year. Equities analysts forecast that Lantheus Holdings will post $1.12 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This news story was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/20/lantheus-holdings-inc-lnth-downgraded-by-zacks-investment-research.html.
In other news, CEO Mary Anne Heino sold 10,000 shares of Lantheus Holdings stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $18.05, for a total value of $180,500.00. Following the completion of the transaction, the chief executive officer now directly owns 592,468 shares in the company, valued at $10,694,047.40. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Avista Capital Partners Gp, Ll sold 87,939 shares of Lantheus Holdings stock in a transaction on Monday, August 14th. The shares were sold at an average price of $17.40, for a total value of $1,530,138.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 906,344 shares of company stock worth $15,499,626. Corporate insiders own 2.30% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. State of Alaska Department of Revenue purchased a new position in Lantheus Holdings during the second quarter worth about $102,000. Municipal Employees Retirement System of Michigan purchased a new position in shares of Lantheus Holdings in the 2nd quarter worth about $107,000. LS Investment Advisors LLC purchased a new position in shares of Lantheus Holdings in the 2nd quarter worth about $112,000. Quantbot Technologies LP purchased a new position in shares of Lantheus Holdings in the 2nd quarter worth about $117,000. Finally, Teachers Retirement System of The State of Kentucky purchased a new position in shares of Lantheus Holdings in the 2nd quarter worth about $141,000. Institutional investors own 84.35% of the company’s stock.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.